Trial
NCT02167360
Study of Efficacy and Safety of CTL019 in Adult ALL Patients
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Abramson Cancer Center at Penn Medicine
Collaborators
—
Condition
B-cell Acute Lymphoblastic Leukemia
Intervention
CTL019
Why stopped
Did not enroll
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-02-14